Drug intelligence / Profile preview

Frekavit

Development stage
Unknown
Lead developer
Fresenius Kabi
Modality
Small Molecules
Administration
Intravenous, Parenteral
01

Overview

Frekavit is a brand of intravenous multivitamin preparations manufactured by Fresenius Kabi, designed to meet the daily requirements of essential vitamins in patients receiving parenteral nutrition. It is available in two distinct formulations: Frekavit fettlöslich (containing fat-soluble vitamins A, D2, E, and K1) and Frekavit wasserlöslich Novum (containing water-soluble vitamins B1, B2, B3, B5, B6, B8, B9, B12, and C). In clinical settings, such as the PANUSCO trial conducted by the University of Heidelberg, Frekavit has been evaluated as part of a supplemental parenteral nutrition regimen alongside chemotherapy (such as the OFF regimen) to support nutritional status and quality of life in patients with advanced pancreatic adenocarcinoma.

Brand names
FrekavitFrekaVit fettlöslichFrekaVit wasserlöslich Novum
Other names
Frekavit fat-solubleFrekavit water-soluble novum
02

Targets

RXRA (Retinoid X receptor alpha)VDR (Vitamin D receptor)RAR (Retinoic acid receptor)

Beyond the preview

Go deeper on Frekavit.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Frekavit.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call